REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139

System, Test, Anticardiolipin Immunological

CORGENIX, INC.

The following data is part of a premarket notification filed by Corgenix, Inc. with the FDA for Reaads Ii Anti-cardiolipin Igg Semi-quantitative Test Kit, Model 11139.

Pre-market Notification Details

Device IDK032868
510k NumberK032868
Device Name:REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139
ClassificationSystem, Test, Anticardiolipin Immunological
Applicant CORGENIX, INC. 12061 TEJON ST. Westminster,  CO  80234
ContactNanci Dexter
CorrespondentNanci Dexter
CORGENIX, INC. 12061 TEJON ST. Westminster,  CO  80234
Product CodeMID  
Subsequent Product CodeDHC
Subsequent Product CodeMSV
CFR Regulation Number866.5660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2003-09-15
Decision Date2003-10-14

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00855360006199 K032868 000
00847817018213 K032868 000
00847817018220 K032868 000
00847817018237 K032868 000
00847817018244 K032868 000
00847817018251 K032868 000
00847817018268 K032868 000
00847817018275 K032868 000
00847817018282 K032868 000
00855360006069 K032868 000
00855360006076 K032868 000
00855360006083 K032868 000
00855360006113 K032868 000
00855360006120 K032868 000
00855360006137 K032868 000
00855360006175 K032868 000
00855360006182 K032868 000
00847817018206 K032868 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.